ABVC BioPharma Inc

NASDAQ:ABVC   3:57:20 PM EDT
0.73
-0.02 (-2.54%)
4:33:25 PM EDT: $0.76 +0.03 (+4.45%)
Products

ABVC BioPharma Provides Vitargus Update Of Phase II Vitargus Study Protocol Received Thai FDA Approval

Published: 11/17/2022 13:48 GMT
ABVC BioPharma Inc (ABVC) - Abvc Biopharma Provides Vitargus® Update - Phase Ii Vitargus® Study Protocol Received Thai FDA Approval.